홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RLAY
#1750
Relay Therapeutics, Inc. Common Stock
10.2
6
+14.77%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+14.77%
월간 변동
+21.42%
6달 변화
+185.79%
년간 변동율
+213.76%
이전 종가
8.9
4
Open
10.2
6
Bid
Ask
Low
10.2
6
High
10.2
6
양
219
마켓
주식
헬스케어
RLAY
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
90.4 M
108.28 M
121.38 M
131.18 M
169.52 M
178.73 M
—
Valuation ratios
Enterprise value
3.85 B
3.05 B
1.67 B
1.41 B
574.14 M
1.43 B
3.08 B
Price to earnings ratio
—
—
-5.81
-4.25
-1.75
-5.25
-11.28
Price to sales ratio
—
—
1 222.3
56.88
58.82
—
—
Price to cash flow ratio
—
—
7.36
4.84
2.36
6.17
13.04
Price to book ratio
—
—
1.78
1.93
0.76
2.56
3.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.36
0.26
0.41
0.39
0.44
0.39
Return on equity %
0.07
0.41
0.31
0.45
0.43
0.49
0.43
Return on invested capital %
65.63
278.88
147.72
187.57
214.71
197.28
—
Gross margin %
100
100
100
100
100
100
—
Operating margin %
67.51
1 204.02
21.67 K
1 460.11
3 722.07
1 971.59
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
63.41
1 201.29
21.04 K
1 338.66
3 374.72
1 800.58
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
56.49
40.14
16
25.44
15.95
22.61
82.63
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.1
0.03
0
0.03
0.01
0.02
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2.04
2.45
1.74
1.37
1.38
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.35
1.17
0.87
0.49
2.24
Net current asset value per share
—
—
9.08
6.28
5.66
3.37
15.33
Tangible book value per share
—
—
8.45
6.12
5.43
3.3
14.96
Working capital per share
—
—
8.52
6.04
5.31
3.22
14.59
Book value per share
—
—
8.47
6.13
5.44
3.3
14.98
뉴스
Relay Therapeutics stock hits 52-week high at 9.64 USD
릴레이 테라퓨틱스 Q4 실적, 수익 예상치를 넘어
Relay earnings beat by $0.09, revenue topped estimates
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
릴레이 테라퓨틱스, FDA 혁신 치료제 지정 후 실적 주목
Relay Therapeutics earnings in spotlight after FDA breakthrough
BB Biotech 2025 회계연도: 660% 이익 급증, 2026년 전망은 신중
Relay earnings in focus as FDA breakthrough fuels optimism
릴레이 테라퓨틱스, FDA 혁신 치료제 지정 후 주가 상승
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status
릴레이 테라퓨틱스 유방암 치료제, FDA 혁신 치료제 지정
FDA grants breakthrough therapy status to Relay’s breast cancer drug